LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

Search

Integra LifeSciences Holdings Corp

Fermé

SecteurSoins de santé

11.41 0.97

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.84

Max

11.56

Chiffres clés

By Trading Economics

Revenu

-459M

-484M

Ventes

-14M

402M

BPA

0.54

Marge bénéficiaire

-116.474

Employés

4,396

EBITDA

526M

54M

Recommandations

By TipRanks

Recommandations

Vente Forte

Prévisions sur 12 Mois

+7.96% upside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-361M

895M

Ouverture précédente

10.44

Clôture précédente

11.41

Sentiment de l'Actualité

By Acuity

46%

54%

148 / 373 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

5 nov. 2025, 23:51 UTC

Résultats

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5 nov. 2025, 23:10 UTC

Résultats

DBS Third Quarter Net Dips 2.0%

5 nov. 2025, 22:55 UTC

Résultats

Arm Holdings 2Q Profit Climbs on Record Demand

5 nov. 2025, 22:23 UTC

Résultats

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5 nov. 2025, 23:52 UTC

Résultats

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5 nov. 2025, 23:49 UTC

Résultats

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5 nov. 2025, 23:49 UTC

Résultats

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5 nov. 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5 nov. 2025, 23:42 UTC

Market Talk

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5 nov. 2025, 23:12 UTC

Résultats

Nutrien 3Q Adj EPS 97c >NTR.T

5 nov. 2025, 23:11 UTC

Résultats

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5 nov. 2025, 23:10 UTC

Résultats

Nutrien 3Q Sales $6.01B >NTR.T

5 nov. 2025, 23:10 UTC

Market Talk
Résultats

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5 nov. 2025, 23:10 UTC

Résultats

Nutrien 3Q EPS 96c >NTR.T

5 nov. 2025, 23:04 UTC

Résultats

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5 nov. 2025, 23:03 UTC

Market Talk

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5 nov. 2025, 22:55 UTC

Market Talk

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5 nov. 2025, 22:55 UTC

Résultats

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5 nov. 2025, 22:51 UTC

Résultats

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5 nov. 2025, 22:50 UTC

Résultats

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5 nov. 2025, 22:44 UTC

Acquisitions, Fusions, Rachats

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5 nov. 2025, 22:43 UTC

Market Talk
Résultats

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5 nov. 2025, 22:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5 nov. 2025, 22:36 UTC

Market Talk

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5 nov. 2025, 22:20 UTC

Market Talk

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5 nov. 2025, 22:12 UTC

Acquisitions, Fusions, Rachats

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5 nov. 2025, 22:11 UTC

Acquisitions, Fusions, Rachats

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5 nov. 2025, 22:11 UTC

Acquisitions, Fusions, Rachats

Pfizer Responds to Delaware Chancery Court Ruling

5 nov. 2025, 22:01 UTC

Résultats

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5 nov. 2025, 22:01 UTC

Résultats

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

7.96% hausse

Prévisions sur 12 Mois

Moyen 12.2 USD  7.96%

Haut 14 USD

Bas 10 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente Forte

5 ratings

0

Achat

1

Maintien

4

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

148 / 373Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat